Sunil K Singh

Array ( [id] => 1478945 [patent_doc_number] => 06451854 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => '-amino acid phenyl ester derivatives' [patent_app_type] => B1 [patent_app_number] => 09/744004 [patent_app_country] => US [patent_app_date] => 2001-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9583 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451854.pdf [firstpage_image] =>[orig_patent_app_number] => 09744004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000547 [patent_doc_number] => 20020028760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Compounds specific for the human alpha1d adrenergic receptor and uses thereof' [patent_app_type] => new [patent_app_number] => 09/764710 [patent_app_country] => US [patent_app_date] => 2001-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15648 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028760.pdf [firstpage_image] =>[orig_patent_app_number] => 09764710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6900287 [patent_doc_number] => 20010009963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-26 [patent_title] => 'Method for crystallizing tryptophan' [patent_app_type] => new [patent_app_number] => 09/756194 [patent_app_country] => US [patent_app_date] => 2001-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1658 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20010009963.pdf [firstpage_image] =>[orig_patent_app_number] => 09756194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478477 [patent_doc_number] => 06344569 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-05 [patent_title] => 'Process for producing 6-cyanomethyl-1,3-dioxane-4-acetic acid derivatives' [patent_app_type] => B1 [patent_app_number] => 09/674178 [patent_app_country] => US [patent_app_date] => 2001-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5840 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/344/06344569.pdf [firstpage_image] =>[orig_patent_app_number] => 09674178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1311972 [patent_doc_number] => 06613787 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-02 [patent_title] => 'Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind in the DNA minor groove as a dimer' [patent_app_type] => B2 [patent_app_number] => 09/745004 [patent_app_country] => US [patent_app_date] => 2000-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10147 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613787.pdf [firstpage_image] =>[orig_patent_app_number] => 09745004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1388100 [patent_doc_number] => 06552230 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Method for preparing 2-nitro-5-(phenylthio)-anilines' [patent_app_type] => B1 [patent_app_number] => 09/720011 [patent_app_country] => US [patent_app_date] => 2000-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2510 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/552/06552230.pdf [firstpage_image] =>[orig_patent_app_number] => 09720011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4279569 [patent_doc_number] => 06281356 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Substituted pyrroles' [patent_app_type] => 1 [patent_app_number] => 9/737685 [patent_app_country] => US [patent_app_date] => 2000-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13733 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/281/06281356.pdf [firstpage_image] =>[orig_patent_app_number] => 737685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1399617 [patent_doc_number] => 06541613 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-04-01 [patent_title] => 'Isoflavone derivatives' [patent_app_type] => B2 [patent_app_number] => 09/737895 [patent_app_country] => US [patent_app_date] => 2000-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4650 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541613.pdf [firstpage_image] =>[orig_patent_app_number] => 09737895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6880591 [patent_doc_number] => 20010031878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-18 [patent_title] => 'Novel processes for making- and a new crystalline form of- leflunomide' [patent_app_type] => new [patent_app_number] => 09/736727 [patent_app_country] => US [patent_app_date] => 2000-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4048 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20010031878.pdf [firstpage_image] =>[orig_patent_app_number] => 09736727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416103 [patent_doc_number] => 06521611 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-18 [patent_title] => 'Non-peptidyl vasopressin V1a antagonists' [patent_app_type] => B2 [patent_app_number] => 09/733430 [patent_app_country] => US [patent_app_date] => 2000-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31885 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/521/06521611.pdf [firstpage_image] =>[orig_patent_app_number] => 09733430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4277300 [patent_doc_number] => 06281210 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent' [patent_app_type] => 1 [patent_app_number] => 9/732088 [patent_app_country] => US [patent_app_date] => 2000-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7167 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 428 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/281/06281210.pdf [firstpage_image] =>[orig_patent_app_number] => 732088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1433411 [patent_doc_number] => 06340701 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-22 [patent_title] => 'Cytotoxic agents comprising taxanes and their therapeutic use' [patent_app_type] => B1 [patent_app_number] => 09/717026 [patent_app_country] => US [patent_app_date] => 2000-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9272 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/340/06340701.pdf [firstpage_image] =>[orig_patent_app_number] => 09717026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1463262 [patent_doc_number] => 06350883 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => 'Method for preparing lactam' [patent_app_type] => B1 [patent_app_number] => 09/721285 [patent_app_country] => US [patent_app_date] => 2000-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3172 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350883.pdf [firstpage_image] =>[orig_patent_app_number] => 09721285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1454698 [patent_doc_number] => 06462199 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Silver halide color photographic light-sensitive material, phenidone compound for use therein, and method of producing the same' [patent_app_type] => B1 [patent_app_number] => 09/716359 [patent_app_country] => US [patent_app_date] => 2000-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23203 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/462/06462199.pdf [firstpage_image] =>[orig_patent_app_number] => 09716359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636445 [patent_doc_number] => 06380213 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Compounds useful as neuro-protective agents' [patent_app_type] => B1 [patent_app_number] => 09/715987 [patent_app_country] => US [patent_app_date] => 2000-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50111 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380213.pdf [firstpage_image] =>[orig_patent_app_number] => 09715987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7643817 [patent_doc_number] => 06429223 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Modified forms of pharmacologically active agents and uses therefor' [patent_app_type] => B1 [patent_app_number] => 09/715767 [patent_app_country] => US [patent_app_date] => 2000-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17301 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/429/06429223.pdf [firstpage_image] =>[orig_patent_app_number] => 09715767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1463256 [patent_doc_number] => 06350880 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => 'Crystalline or crystallized acid addition salt of losartan and purification method of losartan' [patent_app_type] => B1 [patent_app_number] => 09/714339 [patent_app_country] => US [patent_app_date] => 2000-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3461 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350880.pdf [firstpage_image] =>[orig_patent_app_number] => 09714339 [rel_patent_id] =>[rel_patent_doc_number] =>)